RT @JonathanOstrem: @manjuggm All credit for this goes to @KnelsonErik, @LeciaSequist, and Dafna Bar-Sagi. Agree that it's fantastic! https…
@manjuggm All credit for this goes to @KnelsonErik, @LeciaSequist, and Dafna Bar-Sagi. Agree that it's fantastic! https://t.co/8LBba9arr9
RT @VivekSubbiah: A bright future for KRAS inhibitors | Nature Cancer https://t.co/9nEUGp52XP
RT @VivekSubbiah: A bright future for KRAS inhibitors | Nature Cancer https://t.co/9nEUGp52XP
A bright future for KRAS inhibitors | Nature Cancer ✅ Bar-Sagi, and Knelson and Sequist provide their distinct perspectives on this recent tour de force in targeting KRASG12C alterations. https://t.co/dSaLyXBiTI
RT @VivekSubbiah: A bright future for KRAS inhibitors | Nature Cancer https://t.co/9nEUGp52XP
RT @VivekSubbiah: A bright future for KRAS inhibitors | Nature Cancer https://t.co/9nEUGp52XP
RT @VivekSubbiah: A bright future for KRAS inhibitors | Nature Cancer https://t.co/9nEUGp52XP
RT @VivekSubbiah: A bright future for KRAS inhibitors | Nature Cancer https://t.co/9nEUGp52XP
RT @VivekSubbiah: A bright future for KRAS inhibitors | Nature Cancer https://t.co/9nEUGp52XP
RT @VivekSubbiah: A bright future for KRAS inhibitors | Nature Cancer https://t.co/9nEUGp52XP
RT @VivekSubbiah: A bright future for KRAS inhibitors | Nature Cancer https://t.co/9nEUGp52XP
RT @VivekSubbiah: A bright future for KRAS inhibitors | Nature Cancer https://t.co/9nEUGp52XP
RT @VivekSubbiah: A bright future for KRAS inhibitors | Nature Cancer https://t.co/9nEUGp52XP
RT @VivekSubbiah: A bright future for KRAS inhibitors | Nature Cancer https://t.co/9nEUGp52XP
RT @VivekSubbiah: A bright future for KRAS inhibitors | Nature Cancer https://t.co/9nEUGp52XP
RT @VivekSubbiah: A bright future for KRAS inhibitors | Nature Cancer https://t.co/9nEUGp52XP
RT @VivekSubbiah: A bright future for KRAS inhibitors | Nature Cancer https://t.co/9nEUGp52XP
RT @VivekSubbiah: A bright future for KRAS inhibitors | Nature Cancer https://t.co/9nEUGp52XP
RT @VivekSubbiah: A bright future for KRAS inhibitors | Nature Cancer https://t.co/9nEUGp52XP
RT @VivekSubbiah: A bright future for KRAS inhibitors | Nature Cancer https://t.co/9nEUGp52XP
A bright future for KRAS inhibitors | Nature Cancer https://t.co/9nEUGp52XP
closer with #Research #NSCLC #kickCancerskRas
'A bright future for #KRAS inhibitors' https://t.co/0vRC5hxJkt @NatureCancer #lcsm #hcsm @kRasKickers
RT @NatureCancer: 🔴Check our Cancer in Translation piece by @BarDafna @LeciaSequist @KnelsonErik on recent KRAS-G12C inhibitors from precli…
RT @MalakAbed: A bright future for KRAS inhibitors https://t.co/PYjavujL4O
RT @NatureCancer: 🔴Check our Cancer in Translation piece by @BarDafna @LeciaSequist @KnelsonErik on recent KRAS-G12C inhibitors from precli…
RT @SaheliSadanand: Looking to get up to speed on the latest KRAS-G12C inhibitors (I was)? Check out this cool piece in @NatureCancer with…
RT @SaheliSadanand: Looking to get up to speed on the latest KRAS-G12C inhibitors (I was)? Check out this cool piece in @NatureCancer with…
RT @NatureCancer: 🔴Check our Cancer in Translation piece by @BarDafna @LeciaSequist @KnelsonErik on recent KRAS-G12C inhibitors from precli…
RT @NatureCancer: 🔴Check our Cancer in Translation piece by @BarDafna @LeciaSequist @KnelsonErik on recent KRAS-G12C inhibitors from precli…
RT @PeterMacRes: Volume 1, Issue 1 of @NatureCancer is here. Includes this excellent review on KRAS inhibitors for treatment of KRAS mutant…
RT @Aiims1742: Way too much great stuff to read in the inaugural issue of @NatureCancer! Here’s @BarDafna @LeciaSequist & @KnelsonErik on R…
RT @NatureCancer: 🔴Check our Cancer in Translation piece by @BarDafna @LeciaSequist @KnelsonErik on recent KRAS-G12C inhibitors from precli…
RT @NatureCancer: 🔴Check our Cancer in Translation piece by @BarDafna @LeciaSequist @KnelsonErik on recent KRAS-G12C inhibitors from precli…
RT @NatureCancer: 🔴Check our Cancer in Translation piece by @BarDafna @LeciaSequist @KnelsonErik on recent KRAS-G12C inhibitors from precli…
RT @NatureCancer: 🔴Check our Cancer in Translation piece by @BarDafna @LeciaSequist @KnelsonErik on recent KRAS-G12C inhibitors from precli…
RT @SaheliSadanand: Looking to get up to speed on the latest KRAS-G12C inhibitors (I was)? Check out this cool piece in @NatureCancer with…
RT @NatureCancer: 🔴Check our Cancer in Translation piece by @BarDafna @LeciaSequist @KnelsonErik on recent KRAS-G12C inhibitors from precli…
RT @NatureCancer: 🔴Check our Cancer in Translation piece by @BarDafna @LeciaSequist @KnelsonErik on recent KRAS-G12C inhibitors from precli…
RT @NatureCancer: 🔴Check our Cancer in Translation piece by @BarDafna @LeciaSequist @KnelsonErik on recent KRAS-G12C inhibitors from precli…
RT @NatureCancer: 🔴Check our Cancer in Translation piece by @BarDafna @LeciaSequist @KnelsonErik on recent KRAS-G12C inhibitors from precli…
RT @NatureCancer: 🔴Check our Cancer in Translation piece by @BarDafna @LeciaSequist @KnelsonErik on recent KRAS-G12C inhibitors from precli…
RT @SaheliSadanand: Looking to get up to speed on the latest KRAS-G12C inhibitors (I was)? Check out this cool piece in @NatureCancer with…
RT @NatureCancer: 🔴Check our Cancer in Translation piece by @BarDafna @LeciaSequist @KnelsonErik on recent KRAS-G12C inhibitors from precli…
RT @NatureCancer: 🔴Check our Cancer in Translation piece by @BarDafna @LeciaSequist @KnelsonErik on recent KRAS-G12C inhibitors from precli…
RT @NatureCancer: 🔴Check our Cancer in Translation piece by @BarDafna @LeciaSequist @KnelsonErik on recent KRAS-G12C inhibitors from precli…
RT @SaheliSadanand: Looking to get up to speed on the latest KRAS-G12C inhibitors (I was)? Check out this cool piece in @NatureCancer with…
RT @MalakAbed: A bright future for KRAS inhibitors https://t.co/PYjavujL4O
RT @SaheliSadanand: Looking to get up to speed on the latest KRAS-G12C inhibitors (I was)? Check out this cool piece in @NatureCancer with…
RT @SaheliSadanand: Looking to get up to speed on the latest KRAS-G12C inhibitors (I was)? Check out this cool piece in @NatureCancer with…
Looking to get up to speed on the latest KRAS-G12C inhibitors (I was)? Check out this cool piece in @NatureCancer with perspectives from both the bench and the clinic. Lots more great stuff in their inaugural issue too, 👏👏 @alexia_zz @krknrm and Julia!
An interesting perspective on the new generation of KRAS inhibitors. @NatureCancer https://t.co/tZil8VEVn1
RT @NatureCancer: 🔴Check our Cancer in Translation piece by @BarDafna @LeciaSequist @KnelsonErik on recent KRAS-G12C inhibitors from precli…
RT @NatureCancer: 🔴Check our Cancer in Translation piece by @BarDafna @LeciaSequist @KnelsonErik on recent KRAS-G12C inhibitors from precli…
RT @Aiims1742: Way too much great stuff to read in the inaugural issue of @NatureCancer! Here’s @BarDafna @LeciaSequist & @KnelsonErik on R…
RT @NatureCancer: 🔴Check our Cancer in Translation piece by @BarDafna @LeciaSequist @KnelsonErik on recent KRAS-G12C inhibitors from precli…
RT @NatureCancer: 🔴Check our Cancer in Translation piece by @BarDafna @LeciaSequist @KnelsonErik on recent KRAS-G12C inhibitors from precli…
RT @NatureCancer: 🔴Check our Cancer in Translation piece by @BarDafna @LeciaSequist @KnelsonErik on recent KRAS-G12C inhibitors from precli…
🔴Check our Cancer in Translation piece by @BarDafna @LeciaSequist @KnelsonErik on recent KRAS-G12C inhibitors from preclinical and translational perspectives. This format is new and exclusive to @NatureCancer! 'A Bright future for KRAS inhibitors' https:/
Great to see the Nature Publishing Group develop a Cancer themed journal @NatureCancer and have #PDAC featured in the inaugural issue
RT @PeterMacRes: Volume 1, Issue 1 of @NatureCancer is here. Includes this excellent review on KRAS inhibitors for treatment of KRAS mutant…
RT @Aiims1742: Way too much great stuff to read in the inaugural issue of @NatureCancer! Here’s @BarDafna @LeciaSequist & @KnelsonErik on R…
RT @PeterMacRes: Volume 1, Issue 1 of @NatureCancer is here. Includes this excellent review on KRAS inhibitors for treatment of KRAS mutant…
RT @PeterMacRes: Volume 1, Issue 1 of @NatureCancer is here. Includes this excellent review on KRAS inhibitors for treatment of KRAS mutant…
RT @Aiims1742: Way too much great stuff to read in the inaugural issue of @NatureCancer! Here’s @BarDafna @LeciaSequist & @KnelsonErik on R…
RT @Aiims1742: Way too much great stuff to read in the inaugural issue of @NatureCancer! Here’s @BarDafna @LeciaSequist & @KnelsonErik on R…
Volume 1, Issue 1 of @NatureCancer is here. Includes this excellent review on KRAS inhibitors for treatment of KRAS mutant cancers. @PeterMacCC's A/Prof Jayesh Desai is leading the charge for clinical testing of KRAS(G12C) inhibitors in patients 🚀 https:/
RT @Aiims1742: Way too much great stuff to read in the inaugural issue of @NatureCancer! Here’s @BarDafna @LeciaSequist & @KnelsonErik on R…
RT @Aiims1742: Way too much great stuff to read in the inaugural issue of @NatureCancer! Here’s @BarDafna @LeciaSequist & @KnelsonErik on R…
RT @Aiims1742: Way too much great stuff to read in the inaugural issue of @NatureCancer! Here’s @BarDafna @LeciaSequist & @KnelsonErik on R…
RT @Aiims1742: Way too much great stuff to read in the inaugural issue of @NatureCancer! Here’s @BarDafna @LeciaSequist & @KnelsonErik on R…
RT @Aiims1742: Way too much great stuff to read in the inaugural issue of @NatureCancer! Here’s @BarDafna @LeciaSequist & @KnelsonErik on R…
A bright future for KRAS inhibitors https://t.co/PYjavujL4O
RT @Aiims1742: Way too much great stuff to read in the inaugural issue of @NatureCancer! Here’s @BarDafna @LeciaSequist & @KnelsonErik on R…
RT @Aiims1742: Way too much great stuff to read in the inaugural issue of @NatureCancer! Here’s @BarDafna @LeciaSequist & @KnelsonErik on R…
RT @Aiims1742: Way too much great stuff to read in the inaugural issue of @NatureCancer! Here’s @BarDafna @LeciaSequist & @KnelsonErik on R…
RT @Aiims1742: Way too much great stuff to read in the inaugural issue of @NatureCancer! Here’s @BarDafna @LeciaSequist & @KnelsonErik on R…
Way too much great stuff to read in the inaugural issue of @NatureCancer! Here’s @BarDafna @LeciaSequist & @KnelsonErik on RAS targeting in cancer - beautiful timeline starting with discovery to latest G12C inhibitors. https://t.co/V6jpU61gyM https://t